Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF GLOBAL CELL SORTING MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATION
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 KEY TAKEAWAYS
2.2 ARRIVING AT THE GLOBAL CELL SORTING MARKETSIZE
2.2.1 VENDOR POSITIONING GRID
2.2.2 TECHNOLOGY LIFE LINE CURVE
2.2.3 TRIPOD DATA VALIDATION MODEL
2.2.4 MARKET GUIDE
2.2.5 MULTIVARIATE MODELLING
2.2.6 TOP TO BOTTOM ANALYSIS
2.2.7 CHALLENGE MATRIX
2.2.8 APPLICATION COVERAGE GRID
2.2.9 STANDARDS OF MEASUREMENT
2.2.10 VENDOR SHARE ANALYSIS
2.2.11 EPIDEMIOLOGY
2.2.12 DATA POINTS FROM KEY PRIMARY INTERVIEWS
2.2.13 DATA POINTS FROM KEY SECONDARY DATABASES
2.3 GLOBAL CELL SORTING MARKET: RESEARCH SNAPSHOT
2.4 ASSUMPTIONS
3 MARKET OVERVIEW
3.1 DRIVERS
3.2 RESTRAINTS
3.3 OPPORTUNITIES
3.4 CHALLENGES
4 EXECUTIVE SUMMARY
5 EPIDEMIOLOGY
6 PREMIUM INSIGHTS
6.1 PESTAL ANALYSIS
6.2 PORTER’S ANALYSIS
6.3 KEY STRATEGIC INITIAVES
6.4 TECHNOLOGICAL INOVATIONS
6.5 REVIEW FROM END USER
7 INDUSTRY INSIGHTS
7.1 MICRO AND MACRO ECONOMIC FACTORS
7.2 PENETRATION AND GROWTH PROSPECT MAPPING
7.3 KEY PRICING STRATEGIES
7.4 INTERVIEWS WITH SPECIALIST
7.5 ANALYIS AND RECOMMENDATION
8 INTELLECTUAL PROPERTY (IP) PORTFOLIO
8.1 PATENT QUALITY AND STRENGTH
8.2 PATENT FAMILIES
8.3 LICENSING AND COLLABORATIONS
8.4 COMPETITIVE LANDSCAPE
8.5 IP STRATEGY AND MANAGEMENT
8.6 OTHER
9 COST ANALYSIS BREAKDOWN
10 TECHNONLOGY ROADMAP
11 INNOVATION TRACKER AND STRATEGIC ANALYSIS
11.1 MAJOR DEALS AND STRATEGIC ALLIANCES ANALYSIS
11.1.1 JOINT VENTURES
11.1.2 MERGERS AND ACQUISITIONS
11.1.3 LICENSING AND PARTNERSHIP
11.1.4 TECHNOLOGY COLLABORATIONS
11.1.5 STRATEGIC DIVESTMENTS
11.2 NUMBER OF PRODUCTS IN DEVELOPMENT
11.3 STAGE OF DEVELOPMENT
11.4 TIMELINES AND MILESTONES
11.5 INNOVATION STRATEGIES AND METHODOLOGIES
11.6 RISK ASSESSMENT AND MITIGATION
11.7 FUTURE OUTLOOK
12 REGULATORY COMPLIANCE
12.1 REGULATORY AUTHORITIES
12.2 REGULATORY CLASSIFICATIONS
12.3 REGULATORY SUBMISSIONS
12.4 INTERNATIONAL HARMONIZATION
12.5 COMPLIANCE AND QUALITY MANAGEMENT SYSTEMS
12.6 REGULATORY CHALLENGES AND STRATEGIES
13 REIMBURSEMENT FRAMEWORK
14 OPPUTUNITY MAP ANALYSIS
15 VALUE CHAIN ANALYSIS
16 HEALTHCARE ECONOMY
16.1 HEALTHCARE EXPENDITURE
16.2 CAPITAL EXPENDITURE
16.3 CAPEX TRENDS
16.4 CAPEX ALLOCATION
16.5 FUNDING SOURCES
16.6 INDUSTRY BENCHMARKS
16.7 GDP RATION IN OVERALL GDP
16.8 HEALTHCARE SYSTEM STRUCTURE
16.9 GOVERNMENT POLICIES
16.1 ECONOMIC DEVELOPMENT
17 GLOBAL CELL SORTING MARKET, BY CELL TYPE
17.1 OVERVIEW
17.2 HUMAN CELL
17.2.1 BY SORTING TYPE
17.2.1.1. 4-WAY SORTING
17.2.1.2. MULTI-WAY SORTING
17.2.1.3. STRAIGHT-DOWN SORTING
17.3 ANIMAL CELL
17.3.1 BY SORTING TYPE
17.3.1.1. 4-WAY SORTING
17.3.1.2. MULTI-WAY SORTING
17.3.1.3. STRAIGHT-DOWN SORTING
17.4 MICROBIAL CELL
17.4.1 BY SORTING TYPE
17.4.1.1. 4-WAY SORTING
17.4.1.2. MULTI-WAY SORTING
17.4.1.3. STRAIGHT-DOWN SORTING
18 GLOBAL CELL SORTING MARKET, BY PRODUCT AND SERVICE
18.1 OVERVIEW
18.2 PRODUCTS
18.2.1 CELL SORTER
18.2.1.1. BY MODALITY
18.2.1.1.1. BENCHTOP
18.2.1.1.2. PORTABLE
18.2.1.2. BY LASERS OPTION
18.2.1.2.1. UPTO 3
18.2.1.2.2. UPTO 4
18.2.1.2.3. UPTO 5
18.2.1.3. BY IMAGING DETECTOR
18.2.1.3.1. 0
18.2.1.3.2. 6
18.2.1.3.3. OTHERS (IF ANY)
18.2.2 CONSUMBABLES
18.2.2.1. MICROFLUIDIC CHIP
18.2.2.1.1. BY PACKAGING
18.2.2.1.1.1 10 CHIPS PER BOX
18.2.2.1.1.2 25 CHIPS PER BOX
18.2.2.1.1.3 OTHERS
18.2.2.1.2. BY USABILITY
18.2.2.1.2.1 DISPOSABLE
18.2.2.1.2.2 REUSABLE
18.2.2.2. CALIBRATION BEADS
18.2.2.3. OTHERS
18.2.3 REAGENTS AND KITS
18.2.3.1. CELL SEPARATION TYPE
18.2.3.1.1. POSITIVE CELL SEPARATION
18.2.3.1.2. NEGATIVE CELL SEPARATION
18.2.3.2. BEADS TYPE
18.2.3.2.1. S-PLURIBEAD
18.2.3.2.2. M-PLURIBEAD
18.2.3.3. BY SAMPLE TYPE
18.2.3.3.1. WHOLE BLOOD
18.2.3.3.2. BUFFY COAT
18.2.3.3.3. OTHERS
18.2.3.4. BY PRICE RANGE
18.2.3.4.1. BELOW 100 DOLLARS
18.2.3.4.2. 100-300 DOLLARS
18.2.3.4.3. ABOVE 300 DOLLARS
18.2.4 SPECTRAL CELL SORTER ACCESSORIES
18.3 SERVICES
19 GLOBAL CELL SORTING MARKET, BY SORTING TYPE
19.1 OVERVIEW
19.2 4-WAY SORTING
19.3 MULTI-WAY SORTING
19.4 STRAIGHT-DOWN SORTING
20 GLOBAL CELL SORTING MARKET, BY MODE OF OPERATION
20.1 OVERVIEW
20.2 AUTOMATED OPERATION
20.3 MANUAL OPERATION
21 GLOBAL CELL SORTING MARKET, BY TECHNIQUE
21.1 OVERVIEW
21.2 IMMUNODENSITY CELL SEPARATION
21.3 BUOYANCY-ACTIVATED CELL SORTING (SACS)
21.4 MAGNETIC-ACTIVATED CELL SORTING (MACS)
21.5 FLUORESCENCE- BASED DROPLET CELL SORTING
21.6 MICRO-ELECTROMECHANICAL SYSTEMS (MEMS)–MICROFLUIDICS
21.7 OTHERS
22 GLOBAL CELL SORTING MARKET, BY APPLICATION
22.1 OVERVIEW
22.2 RESEARCH APPLICATIONS
22.2.1 PHYSIOLOGICAL RESEARCH
22.2.2 PROTEIN ENGINEERING
22.2.3 CELL ENGINEERING
22.2.4 STEM CELL RESEARCH
22.3 CLINICAL APPLICATIONS
22.3.1 CANCER CELL SCREENING
22.3.2 INFECTIOUS DISEASES
22.3.3 OTHERS
22.4 OTHERS (IF ANY)
23 GLOBAL CELL SORTING MARKET, BY END USER
23.1 OVERVIEW
23.2 MEDICAL AND ACADEMIC INSTITUTIONS
23.3 RESEARCH INSTITUTIONS AND ACADEMIC INSTITUTIONS
23.4 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
23.4.1 SMALL
23.4.2 MEDIUM
23.4.3 LARGE
23.5 HOSPITALS AND CLINICAL TESTING LABORATORIES
23.5.1 PUBLIC
23.5.2 PRIVATE
23.6 DIAGNOSTIC LABORATORIES
23.7 OTHERS
24 GLOBAL CELL SORTING MARKET, BY DISTRIBUTION CHANNEL
24.1 OVERVIEW
24.2 DIRECT TENDER
24.3 RETAIL SALES
24.4 OTHERS
25 GLOBAL CELL SORTING MARKET, COMPANY LANDSCAPE
25.1 COMPANY SHARE ANALYSIS: GLOBAL
25.2 COMPANY SHARE ANALYSIS: NORTH AMERICA
25.3 COMPANY SHARE ANALYSIS: EUROPE
25.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
25.5 MERGERS & ACQUISITIONS
25.6 NEW PRODUCT DEVELOPMENT & APPROVALS
25.7 EXPANSIONS
25.8 REGULATORY CHANGES
25.9 PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS
26 GLOBAL CELL SORTING MARKET, BY GEOGRAPHY
GLOBAL CELL SORTING MARKET, (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)
26.1 NORTH AMERICA
26.1.1 U.S.
26.1.2 CANADA
26.1.3 MEXICO
26.2 EUROPE
26.2.1 GERMANY
26.2.2 FRANCE
26.2.3 U.K.
26.2.4 HUNGARY
26.2.5 LITHUANIA
26.2.6 AUSTRIA
26.2.7 IRELAND
26.2.8 NORWAY
26.2.9 POLAND
26.2.10 ITALY
26.2.11 SPAIN
26.2.12 RUSSIA
26.2.13 TURKEY
26.2.14 NETHERLANDS
26.2.15 SWITZERLAND
26.2.16 REST OF EUROPE
26.3 ASIA-PACIFIC
26.3.1 JAPAN
26.3.2 CHINA
26.3.3 SOUTH KOREA
26.3.4 INDIA
26.3.5 SINGAPORE
26.3.6 THAILAND
26.3.7 INDONESIA
26.3.8 MALAYSIA
26.3.9 PHILIPPINE
26.3.10 AUSTRALIA
26.3.11 NEW ZEALAND
26.3.12 VIETNAM
26.3.13 TAIWAN
26.3.14 REST OF ASIA-PACIFIC
26.4 SOUTH AMERICA
26.4.1 BRAZIL
26.4.2 ARGENTINA
26.4.3 REST OF SOUTH AMERICA
26.5 MIDDLE EAST AND AFRICA
26.5.1 SOUTH AFRICA
26.5.2 SAUDI ARABIA
26.5.3 UAE
26.5.4 EGYPT
26.5.5 KUWAIT
26.5.6 ISRAEL
26.5.7 REST OF MIDDLE EAST AND AFRICA
26.6 KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES
27 GLOBAL CELL SORTING MARKET, SWOT AND DBMR ANALYSIS
28 GLOBAL CELL SORTING MARKET, COMPANY PROFILE
28.1 MOLECULAR MACHINES AND INDUSTRIES GMBH
28.1.1 COMPANY OVERVIEW
28.1.2 REVENUE ANALYSIS
28.1.3 GEOGRAPHIC PRESENCE
28.1.4 PRODUCT PORTFOLIO
28.1.5 RECENT DEVELOPMENTS
28.2 BIO-RAD LABORATORIES, INC.
28.2.1 COMPANY OVERVIEW
28.2.2 REVENUE ANALYSIS
28.2.3 GEOGRAPHIC PRESENCE
28.2.4 PRODUCT PORTFOLIO
28.2.5 RECENT DEVELOPMENTS
28.3 DANAHER CORPORATION
28.3.1 COMPANY OVERVIEW
28.3.2 REVENUE ANALYSIS
28.3.3 GEOGRAPHIC PRESENCE
28.3.4 PRODUCT PORTFOLIO
28.3.5 RECENT DEVELOPMENTS
28.4 MILTENYI BIOTEC AND/OR ITS AFFILIATES
28.4.1 COMPANY OVERVIEW
28.4.2 REVENUE ANALYSIS
28.4.3 GEOGRAPHIC PRESENCE
28.4.4 PRODUCT PORTFOLIO
28.4.5 RECENT DEVELOPMENTS
28.5 SONY BIOTECHNOLOGY INC
28.5.1 COMPANY OVERVIEW
28.5.2 REVENUE ANALYSIS
28.5.3 GEOGRAPHIC PRESENCE
28.5.4 PRODUCT PORTFOLIO
28.5.5 RECENT DEVELOPMENTS
28.6 UNION BIOMETRICA, INC.
28.6.1 COMPANY OVERVIEW
28.6.2 REVENUE ANALYSIS
28.6.3 GEOGRAPHIC PRESENCE
28.6.4 PRODUCT PORTFOLIO
28.6.5 RECENT DEVELOPMENTS
28.7 STEMCELL TECHNOLOGIES
28.7.1 COMPANY OVERVIEW
28.7.2 REVENUE ANALYSIS
28.7.3 GEOGRAPHIC PRESENCE
28.7.4 PRODUCT PORTFOLIO
28.7.5 RECENT DEVELOPMENTS
28.8 TERUMO BCT, INC.
28.8.1 COMPANY OVERVIEW
28.8.2 REVENUE ANALYSIS
28.8.3 GEOGRAPHIC PRESENCE
28.8.4 PRODUCT PORTFOLIO
28.8.5 RECENT DEVELOPMENTS
28.9 NANOCELLECT BIOMEDICAL
28.9.1 COMPANY OVERVIEW
28.9.2 REVENUE ANALYSIS
28.9.3 GEOGRAPHIC PRESENCE
28.9.4 PRODUCT PORTFOLIO
28.9.5 RECENT DEVELOPMENTS
28.1 ABGENEX PVT. LTD
28.10.1 COMPANY OVERVIEW
28.10.2 REVENUE ANALYSIS
28.10.3 GEOGRAPHIC PRESENCE
28.10.4 PRODUCT PORTFOLIO
28.10.5 RECENT DEVELOPMENTS
28.11 BD
28.11.1 COMPANY OVERVIEW
28.11.2 REVENUE ANALYSIS
28.11.3 GEOGRAPHIC PRESENCE
28.11.4 PRODUCT PORTFOLIO
28.11.5 RECENT DEVELOPMENTS
28.12 CYTONOME/ST, LLC
28.12.1 COMPANY OVERVIEW
28.12.2 REVENUE ANALYSIS
28.12.3 GEOGRAPHIC PRESENCE
28.12.4 PRODUCT PORTFOLIO
28.12.5 RECENT DEVELOPMENTS
28.13 ON-CHIP BIOTECHNOLOGIES CO., LTD.
28.13.1 COMPANY OVERVIEW
28.13.2 REVENUE ANALYSIS
28.13.3 GEOGRAPHIC PRESENCE
28.13.4 PRODUCT PORTFOLIO
28.13.5 RECENT DEVELOPMENTS
28.14 THERMO FISHER SCIENTIFIC INC.
28.14.1 COMPANY OVERVIEW
28.14.2 REVENUE ANALYSIS
28.14.3 GEOGRAPHIC PRESENCE
28.14.4 PRODUCT PORTFOLIO
28.14.5 RECENT DEVELOPMENTS
28.15 PLURISELECT LIFE SCIENCE UG (HAFTUNGSBESCHRÄNKT) & CO. KG
28.15.1 COMPANY OVERVIEW
28.15.2 REVENUE ANALYSIS
28.15.3 GEOGRAPHIC PRESENCE
28.15.4 PRODUCT PORTFOLIO
28.15.5 RECENT DEVELOPMENTS
28.16 CELLULAR HIGHWAYS LTD (A TTP PLC COMPANY)
28.16.1 COMPANY OVERVIEW
28.16.2 REVENUE ANALYSIS
28.16.3 GEOGRAPHIC PRESENCE
28.16.4 PRODUCT PORTFOLIO
28.16.5 RECENT DEVELOPMENTS
28.17 NAMOCELL
28.17.1 COMPANY OVERVIEW
28.17.2 REVENUE ANALYSIS
28.17.3 GEOGRAPHIC PRESENCE
28.17.4 PRODUCT PORTFOLIO
28.17.5 RECENT DEVELOPMENTS
28.18 SYSMEX EUROPE SE
28.18.1 COMPANY OVERVIEW
28.18.2 REVENUE ANALYSIS
28.18.3 GEOGRAPHIC PRESENCE
28.18.4 PRODUCT PORTFOLIO
28.18.5 RECENT DEVELOPMENTS
28.19 MOLECULAR DEVICES, LLC
28.19.1 COMPANY OVERVIEW
28.19.2 REVENUE ANALYSIS
28.19.3 GEOGRAPHIC PRESENCE
28.19.4 PRODUCT PORTFOLIO
28.19.5 RECENT DEVELOPMENTS
28.2 CELL MICROSYSTEMS
28.20.1 COMPANY OVERVIEW
28.20.2 REVENUE ANALYSIS
28.20.3 GEOGRAPHIC PRESENCE
28.20.4 PRODUCT PORTFOLIO
28.20.5 RECENT DEVELOPMENTS
28.21 XIAMEN WINACK BATTERY TECHNOLOGY CO., LTD
28.21.1 COMPANY OVERVIEW
28.21.2 REVENUE ANALYSIS
28.21.3 GEOGRAPHIC PRESENCE
28.21.4 PRODUCT PORTFOLIO
28.21.5 RECENT DEVELOPMENTS
28.22 SPHERE FLUIDICS.
28.22.1 COMPANY OVERVIEW
28.22.2 REVENUE ANALYSIS
28.22.3 GEOGRAPHIC PRESENCE
28.22.4 PRODUCT PORTFOLIO
28.22.5 RECENT DEVELOPMENTS
28.23 NEBULA ELECTRONIC CO. LTD.
28.23.1 COMPANY OVERVIEW
28.23.2 REVENUE ANALYSIS
28.23.3 GEOGRAPHIC PRESENCE
28.23.4 PRODUCT PORTFOLIO
28.23.5 RECENT DEVELOPMENTS
NOTE: THE COMPANIES PROFILED IS NOT EXHAUSTIVE LIST AND IS AS PER OUR PREVIOUS CLIENT REQUIREMENT. WE PROFILE MORE THAN 100 COMPANIES IN OUR STUDY AND HENCE THE LIST OF COMPANIES CAN BE MODIFIED OR REPLACED ON REQUEST
29 RELATED REPORTS
30 CONCLUSION
31 QUESTIONNAIRE
32 ABOUT DATA BRIDGE MARKET RESEARCH
